Juvenile Diabetes Research Foundation
26 Broadway
14th Floor
New York
New York
10004
United States
Tel: 212-479-7571 or 800-533-CURE
Website: http://www.jdrf.org/
Email: info@jdrf.org
95 articles about Juvenile Diabetes Research Foundation
-
JDRF and its affiliates celebrate Teplizumab approval
11/22/2022
JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds the decision from the U.S Food and Drug Administration (FDA) to approve Provention Bio’s teplizumab.
-
Lundquist Institute Investigator Eiji Yoshihara, PhD., Receives Internationally Prestigious Award for Research on Type 1 Diabetes
3/16/2022
The Lundquist Institute's investigator Eiji Yoshihara, Ph.D., has received a five-year $749,995.50 Career Development Award from JDRF for his proposed study on how human β cells gain immune evasive function by environmental cues.
-
Funding commitment helps remove barriers to life-saving technology for Canadians living with type 1 diabetesTD Bank Group supports JDRF's Access for All program through the TD Ready Commitment May 26, 2021
5/26/2021
Each day, as many as 300,000 Canadians living with type 1 diabetes will make up to 300 decisions about their care.
-
JDRF Canada is marking National Diabetes Awareness Month by asking those impacted to write a letter to type 1 diabetes with the launch of their "Dear Type 1" Campaign
11/10/2020
JDRF Canada, the leading organization funding type 1 diabetes research, is marking National Diabetes Awareness Month by honouring the power and resilience of the T1D community with the “Dear Type 1” campaign.
-
Max Domi launches fund to help Canadians living with type 1 diabetes
10/25/2019
Montreal Canadiens centre and JDRF ambassador, Max Domi, unveiled The Max Domi Fund for Type 1 Diabetes at the Bell Sports Complex.
-
JDRF Funds Zucara Therapeutics' Approach To Preventing Hypoglycemia In People With Type 1 Diabetes
9/21/2017
-
JDRF-Funded Study Finds That Continuous Glucose Monitoring For Pregnant Women With Type 1 Diabetes Improves Health Of Mother And Newborn
9/15/2017
-
JDRF And vTv Therapeutics Announce Collaboration On Phase II Study Of Novel Treatment For Type 1 Diabetes
9/6/2017
-
American Diabetes Association, JDRF And Insulin For Life Respond To Catastrophic Flooding Due To Hurricane Harvey In Texas
8/30/2017
-
American Diabetes Association And JDRF Partnering To Provide Emergency Support For People With Diabetes Impacted By Hurricane Harvey
8/29/2017
-
JDRF Taps Former Miss America And Renowned Diabetes Advocate Dr. Nicole Johnson As National Director Of Mission
8/23/2017
-
JDRF And IBM Collaborate To Research Risk Factors For Type 1 Diabetes In Childrendelete
8/18/2017
-
JDRF And ViaCyte Announce Support For Development Of PEC-Direct Cell Replacement Therapy For Type 1 Diabetes
5/22/2017
-
JDRF Release: New Research Identifies Novel Target For Controlling Immune Response To Implanted Materials
3/21/2017
-
GluSense Ltd. Receives Investment From JDRF T1D Fund
2/16/2017
-
JDRF Launches Early-Stage Investment Fund To Catalyze Development Of Commercial Type 1 Diabetes Therapies
1/26/2017
-
Lexicon Pharma Reports Top-Line Results From Phase 2 Clinical Trial Conducted In Collaboration With Juvenile Diabetes Research Foundation
12/6/2016
-
Becton, Dickinson and Company Collaborates With Juvenile Diabetes Research Foundation To Focus On Extended Wear Innovations For Insulin Infusion Delivery
11/11/2016
-
Juvenile Diabetes Research Foundation Celebrates FDA Approval of Artificial Pancreas System
9/29/2016
-
AnTolRx Announces Series A Equity Funding From Pfizer, Juvenile Diabetes Research Foundation And Orion Equity Partners To Develop Targeted Nanoparticle Tolerance Therapeutics
9/8/2016